Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Urogenital Neoplasms × Manual Lymphatic Drainage × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Lymphedema 9 Breast Neoplasms 9 Neoplasm Metastasis 2 Breast Cancer Lymphedema 2 Urogenital Neoplasms 1 Lymphedema of Upper Arm 1 Fibromyalgia 1 Edema 1 Axillary Web Syndrome 1

Interventions

pembrolizumab 4 padeliporfin 4 Nivolumab 4 Ipilimumab 4 fludarabine 3 atezolizumab 3 aldesleukin 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Cyclophosphamide 3 vedolizumab 2 olaparib 2 cabozantinib 2 anlotinib 2 abiraterone 2 Therapeutics 2 Sunitinib 2 Standard of Care 2 Riluzole 2 Prednisone 2 Pluvicto 2 Paclitaxel 2 LDP-02 2 Infliximab 2 Immunoglobulin G 2 Genetic Testing 2 Gemcitabine 2 Fecal Microbiota Transplantation 2 Drug Therapy 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05266157 2024-06-28

UroLymph

Universitaire Ziekenhuizen KU Leuven

Phase NA Recruiting

Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡